Providing organizational and infrastructure support to facilitate activities and programs that strengthen and enrich the HIV research environment in Texas.
Supporting targeted high-priority interdisciplinary pilot research projects, assisting in responding to new HIV-related research initiatives and facilitating research on ending HIV and improving health of people with HIV in Texas.
Providing state-of-the-art expertise, advice and services to facilitate the range of HIV-related research for investigators at the Texas D-CFAR institutions. “As new antiretroviral drugs became available, the life expectancy of people with HIV bumped up to that of the general population. However, our current research should address the emergence of comorbidities such as cardiovascular, liver, kidney and bone diseases and cancer, among others, observed in the aging population with HIV. The Texas D-CFAR has a pivotal role bringing established and new investigators with expertise on different fields together and providing them the tools and support to address these problems,” said Dr. Roberto C. Arduino, Texas D-CFAR co-director for UTHealth and professor of infectious disease at McGovern Medical School. “This will be the groundwork to develop new research and to develop new investigators doing HIV research and to increase the partnerships across the academic research institutions, the public health entities and the community. It takes a whole team to make an impact on the HIV epidemic across the state and worldwide,” Giordano said. Dr. Deepak Kaushal serves as the Texas D-CFAR co-director for Texas Biomedical Research Institute. Dr. Andrew Rice, professor of molecular virology and microbiology, is the co-director for Baylor College of Medicine.
Source
News Highlights Health
- NIH Funds Texas Institutes of Health for HIV Research
- Check all news and articles from the Health news information updates.
